The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125254781 12525478 1 I 20160109 20160629 20160704 20160704 EXP US-ASTRAZENECA-2016SE72267 ASTRAZENECA 322.00 DY M Y 8.60000 KG 20160705 MD DE DE

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125254781 12525478 1 PS SYNAGIS PALIVIZUMAB 1 Intramuscular U U 0 100 MG INJECTION QD
125254781 12525478 2 SS SYNAGIS PALIVIZUMAB 1 Intramuscular U U 0 100 MG INJECTION QD
125254781 12525478 3 SS SYNAGIS PALIVIZUMAB 1 Intramuscular U U 0 100 MG INJECTION QD
125254781 12525478 4 SS SYNAGIS PALIVIZUMAB 1 Intramuscular U U 0 100 MG INJECTION QD
125254781 12525478 5 SS SYNAGIS PALIVIZUMAB 1 Intramuscular U U 0 100 MG INJECTION QD
125254781 12525478 6 SS SYNAGIS PALIVIZUMAB 1 Intramuscular U U 0 100 MG INJECTION QD
125254781 12525478 7 SS SYNAGIS PALIVIZUMAB 1 Intramuscular U U 0 100 MG INJECTION QD
125254781 12525478 8 SS SYNAGIS PALIVIZUMAB 1 Intramuscular U U 0 100 MG INJECTION QD
125254781 12525478 9 C SALBUTAMOL ALBUTEROL 1 0
125254781 12525478 10 C FLUORETTE 2 0 503 MG
125254781 12525478 11 C SULTANOL ALBUTEROL SULFATE 1 0
125254781 12525478 12 C IPRATROPIUM BROMIDE. IPRATROPIUM BROMIDE 1 0
125254781 12525478 13 C ATROVENT IPRATROPIUM BROMIDE 1 0
125254781 12525478 14 C BUPARID 2 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125254781 12525478 1 Antiviral prophylaxis
125254781 12525478 2 Premature baby
125254781 12525478 3 Antiviral prophylaxis
125254781 12525478 4 Premature baby
125254781 12525478 5 Antiviral prophylaxis
125254781 12525478 6 Premature baby
125254781 12525478 7 Antiviral prophylaxis
125254781 12525478 8 Premature baby
125254781 12525478 9 Product used for unknown indication
125254781 12525478 10 Product used for unknown indication
125254781 12525478 11 Product used for unknown indication
125254781 12525478 12 Product used for unknown indication
125254781 12525478 13 Product used for unknown indication
125254781 12525478 14 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
125254781 12525478 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
125254781 12525478 Bronchitis
125254781 12525478 Oxygen saturation decreased
125254781 12525478 Pseudocroup
125254781 12525478 Respiratory failure
125254781 12525478 Tracheitis

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125254781 12525478 1 20151208 20151208 0
125254781 12525478 2 20151208 20151208 0
125254781 12525478 3 20160106 20160106 0
125254781 12525478 4 20160106 20160106 0
125254781 12525478 5 20160202 20160202 0
125254781 12525478 6 20160202 20160202 0
125254781 12525478 7 20160406 20160406 0
125254781 12525478 8 20160406 20160406 0
125254781 12525478 12 20160111 0